Biogen Inc (BIIB)
Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell
$124.02
Buy
$126.98
$-0.49 (-0.39%)
Prices updated at 23 May 2025, 23:03 EDT
| Prices minimum 15 mins delay
Prices in USD
Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological, rare and autoimmune diseases.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
In the news
Sharecast service unavailable
Press releases
Key dates
| Forecast date | |
|---|---|
| Annual report | Feb 2026 |
| Final results | Feb 2026 |
| Half yearly results | Aug 2025 |
| Annual general meeting | Jun 2025 |
| Previous date | |
|---|---|
| Annual report | Feb 2025 |
| Final results | Feb 2025 |
| Half yearly results | Aug 2024 |
| Annual general meeting | Jun 2024 |
Company reports
31 Dec 2023
Annual Report 30 Sep 2023
Quarterly Report 